The deterioration of chronic heart failure – so-called worsening heart failure (WHF) – is no longer solely an acute event, but an expression of complex, often repetitive pathophysiological dynamics. Despite improved pharmacotherapy, earlier diagnosis and more sophisticated monitoring, the hospitalization rate remains high and mortality within the first year after discharge is a cause for concern. New data show that WHF is not only the final stage of advanced heart failure, but is often triggered by treatable mechanisms: Volume shifts, inadequate neurohormone blockade, inflammatory or metabolic triggers and inadequate adherence to therapy.
You May Also Like
- Migraine
Fremanezumab for comorbid migraine and depression
- Case study
Moyamoya disease in a 23-year-old female patient
- Dapagliflozin for T2D and heart failure
Epicardial fat reduced in patients with type 2 diabetes and HF
- A hub of biological aging
Mitochondrial dysfunction and energy metabolism
- Health Literacy
Promoting health literacy: from the abstract to the concrete level
- Pharmacological therapy
Anxiety symptoms in eating disorders
- Case study
Wiedemann-Steiner syndrome in a 2-year-old girl
- Evidence, limitations and practical implications